Jain Global’s Damora Therapeutics DMRA Stock Holding History

Jain Global’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120,566	Closed	-$2.77M	–	1375
2025 Q4	$2.77M	Buy	+120,566	New	+$2.1M	0.01%	533

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Jain Global's DMRA Position: Q1 2026 in Review

Jain Global sold out of Damora Therapeutics (DMRA) in Q1 2026, closing a stake of 120,566 shares — an estimated $2.77M sold.

Jain Global first reported a position in DMRA in Q4 2025 and held it in 1 quarter. The position peaked at $2.77M in Q4 2025. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

Jain Global reported no remaining Damora Therapeutics position as of Q1 2026 after selling out during the quarter.
Jain Global sold 120,566 Damora Therapeutics shares in Q1 2026, an estimated $2.77M.
Jain Global first reported a position in Damora Therapeutics in Q4 2025 and held it in 1 quarter.
Jain Global's Damora Therapeutics position peaked at $2.77M in Q4 2025.
65 funds tracked by Wall St. Rank held Damora Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.